New Key Statistics Module, Z-Score and F-Score
NAS:SILO Key Ratios
| Market Cap $ M | 5.26 |
| Enterprise Value $ M | -2.40 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.87 |
| Price/Sales | 77.08 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -1.20 |
| Beneish M-Score | -4.03 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.66 |
| EV-to-EBITDA | 0.66 |
| PEG | -- |
| Shares Outstanding M | 2.84 |
| Net Margin (%) | -5,138.89 |
| Operating Margin % | -5,354.17 |
| Pre-tax Margin (%) | -5,043.06 |
| Quick Ratio | 9.90 |
| Current Ratio | 9.90 |
| ROA % (ttm) | -37.26 |
| ROE % (ttm) | -44.31 |
| ROIC % (ttm) | -2,753.57 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.42 |
SILO Number of Guru Trades
SILO Volume of Guru Trades
Gurus Latest Trades with NAS:SILO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SILO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SILO Pharma Inc Insider Transactions
No Available Data
News about NAS:SILO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers